Bedaquiline Fumarate
Product Description
OMGENE LIFE SCIENCES PRIVATE LIMITED
-
IN
-
2020On CPHI since
-
50 - 99Employees
Company types
Categories
Specifications
OMGENE LIFE SCIENCES PRIVATE LIMITED
-
IN
-
2020On CPHI since
-
50 - 99Employees
Company types
More Products from OMGENE LIFE SCIENCES PRIVATE LIMITED (44)
-
Product Semaglutide
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus , to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and est... -
Product Rezafungin
Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. -
Product Tirzepatide
Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Product Cetrorelix Acetate
Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation. -
Product Degarelix Acetate
Indicated for treatment of patients with advanced prostate cancer. -
Product Apremilast
Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease -
Product Binimetinib
Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation -
Product Brivaracetam
Indicated for the treatment of partial-onset seizures in patients 4 years of age and older. -
Product Carbetocin
Used to prevent excessive bleeding after childbirth, particularly following Cesarean section. -
Product Crisaborole
Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. -
Product Deutetrabenazine
Indicated for the treatment of chorea associated with Huntington’s disease, tardive dyskinesia in adults.
-
Product Erdafitinib
Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva...
OMGENE LIFE SCIENCES PRIVATE LIMITED resources (1)
-
Brochure Brochure of Company
Brochure of the company for referring to Company's work profile, strengths, capabilities and facility information.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance